Cilostazol
CAS No. 73963-72-1
Cilostazol ( OPC 13013;OPC 21 )
Catalog No. M15825 CAS No. 73963-72-1
Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 35 | In Stock |
|
50MG | 48 | In Stock |
|
100MG | 69 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCilostazol
-
NoteResearch use only, not for human use.
-
Brief DescriptionCilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
-
DescriptionCilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo. The compound relaxes vascular smooth muscle and inhibits mitogenesis and migration of vascular smooth muscle cells; also upregulates autophagy via SIRT1 activation, has preventive effects on various central nervous system (CNS) diseases.Stroke Approved
-
SynonymsOPC 13013;OPC 21
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE3
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number73963-72-1
-
Formula Weight369.46
-
Molecular FormulaC20H27N5O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
-
Chemical Name2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schrr K, et al. Diabetes Obes Metab. 2002 Mar;4 Suppl 2:S14-9.
2. Lee HR, et al. PLoS One. 2015 Aug 5;10(8):e0134486.
3. Qi DS, et al. Brain Res. 2016 Dec 15;1653:67-74.
2. Lee HR, et al. PLoS One. 2015 Aug 5;10(8):e0134486.
3. Qi DS, et al. Brain Res. 2016 Dec 15;1653:67-74.
molnova catalog
related products
-
BC 11-38
BC 11-38 is a potent, selective PDE biodepressant which is mainly effective against PDE11 (IC50 : 0.28 μM).
-
BRL 50481
BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.
-
Enpp-1-IN-14
ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.